New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
09:58 EDTTC, SSI, SAP, EDU, PGH, MNTA, NSLP, LPI, DECK, CPE, BWLD, BPTH, AVGOOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Avago (AVGO) reinstated with an Overweight at Barclays... Bio-Path Holdings (BPTH) initiated with a Buy at Maxim... Buffalo Wild Wings (BWLD) initiated with an Underperform at Buckingham... Callon Petroleum (CPE) assumed with a Buy at Brean Capital... Deckers Outdoor (DECK) initiated with an Outperform at Macquarie... Laredo Petroleum (LPI) assumed with a Buy at Brean Capital... Momenta Pharma (MNTA) initiated with a Buy at Maxim... New Oriental Education (EDU) initiated with an Overweight at JPMorgan... New Source Energy (NSLP) initiated with a Buy at Wunderlich... Pengrowth Energy (PGH) coverage assumed with a Sector Perform at RBC Capital... SAP (SAP) initiated with a Market Perform at BMO Capital... Stage Stores (SSI) initiated with a Buy at BofA/Merrill... Thompson Creek (TC) initiated with a Market Perform at BMO Capital.
News For AVGO;BPTH;BWLD;CPE;DECK;LPI;MNTA;EDU;NSLP;PGH;SSI;SAP;TC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 26, 2015
08:01 EDTDECKDeckers Outdoor opens pop-up shops in Boston and New York
Subscribe for More Information
06:44 EDTSAPWorkday valuation contingent on competitors in cloud market, WSJ reports
Subscribe for More Information
August 25, 2015
15:02 EDTMNTAMylan says USPTO institutes IPR of two Copaxone patents
Subscribe for More Information
14:40 EDTMNTATeva Copaxone patents to be reconsidered by regulators, Bloomberg says
09:59 EDTAVGOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:30 EDTAVGO, AVGOAvago upgraded to Buy from Outperform at CLSA
Subscribe for More Information
August 24, 2015
09:45 EDTAVGOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTAVGOAvago downgraded to Sell from Hold at Drexel Hamilton
Drexel Hamilton downgraded Avago (AVGO) to Sell and reduced its price target to $95 from $125. The firm said Broadcom (BRCM) acquisition will require large amounts of debt and financing will be difficult given the situation in the capital markets.
06:22 EDTAVGOTSMC pursuing 16nm chip orders, DigiTimes reports
According to market sources, DigiTimes reports that TSMC (TSM) has been "actively" seeking 16nm FinFET chip orders. In addition to securing a portion of Apple's (AAPL) A9 chip orders, TSMC has also received orders from AMD (AMD), Broadcom (BRCM), LG, Nvidia (NVDA) and Avago (AVGO), the sources say, noting that TSMC failed to maintain orders for Qualcomm's (QCOM) flagship mobile chips, as it has placed orders for the Snapdragon 820 series with Samsung (SSNLF). Reference Link
August 21, 2015
10:02 EDTSSIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:53 EDTSSIStage Stores downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill downgraded Stage Stores two notches to Underperform from Buy and lowered its price target to $12 from $24. Following the disappointing Q2 report and FY15 guidance, the firm said it no longer has confidence in turnaround initiatives and expects continued layoffs through 2016 to pressure next year's growth.
06:56 EDTSSIStage Stores downgraded to Neutral from Buy at B. Riley
B. Riley downgraded Stage Stores to Neutral and lowered its price target to $14 from $20 citing the Q2 miss and lowered guidance.
05:35 EDTSSIStage Stores downgraded to Neutral from Buy at B. Riley
B. Riley analyst Jeff Van Sinderen downgraded Stage Stores to Neutral citing caution over the company's second half of 2015 after its Q2 results missed expectations and guidance was reduced. The analyst cut his price target for shares to $14 from $20.
August 20, 2015
16:48 EDTSSIOn The Fly: Top stock stories for Thursday
Subscribe for More Information
07:45 EDTBPTHBio-Path Holdings management to meet with Roth Capital
Meeting to be held in New York on August 26 hosted by Roth Capital.
07:31 EDTMNTAMomenta shares offer 'significant opportunity,' says Bernstein
Bernstein analyst Ronny Gal sees a "significant opportunity" in shares of Momenta Pharmaceuticals over the next few months. Copaxone sales should prove durable as a competing approval is unlikely until mid-2016, Gal tells investors in a research note. The analyst sees limited share downside before year-end and raised his price target for the stock to $31. He keeps an Outperform rating on Momenta.
06:03 EDTSSIStage Stores reports Q2 comparable sales up 0.8%
06:02 EDTSSIStage Stores cuts FY15 adjusted EPS to $1.05-$1.15 from $1.20-$1.28
Subscribe for More Information
06:01 EDTSSIStage Stores: Q2 challenged by weaker peso, economic softness US
Subscribe for More Information
06:01 EDTSSIStage Stores reports Q2 adjusted EPS 22c, consensus 34c
Reports Q2 revenue $380.92M, consensus $384.63M.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use